Nature·4 min read·hard
In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer
G
Galal, Soaad
✦AI Summary
Researchers have utilized in vivo CRISPR/Cas9 screening to identify specific genes that act as metastasis suppressors in triple-negative breast cancer. The study highlights how the loss of these genes promotes tumor progression and suggests potential targets for future therapeutic intervention.
Nature Communications ( 2026 ) Cite this article
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in